Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Cocokara Fine (3098 JP)
Watchlist
47
Analysis
Consumer Staples
•
Japan
cocokara fine Inc. is a holding company established through a merger of SEIJO Corporation and Segami Medics. The Company operates drug chain stores which sell medicines, health food, cosmetics, nursery items and daily necessity goods.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Cocokara Fine
•
29 Sep 2019 02:05
Cocokara and Matsukiyo: Potential Competition for Supermarkets and Convenience Stores
After several months of cross-company negotiations around tie-ups, late in August Cocokara Fine (3098 JP and Matsumotokiyoshi Holdings Co (3088 JP)...
Michael Causton
Follow
717 Views
Share
bullish
•
MatsukiyoCocokara
•
23 Aug 2019 13:49
Matsukiyo: No Loss of Emphasis on Profitability, Looking to ASEAN for Growth
Following yesterday's press briefing, a number of Nikkei articles are out in Japanese (12) which are not currently available on their English...
Mio Kato
Follow
593 Views
Share
bullish
•
MatsukiyoCocokara
•
16 Aug 2019 17:10
Matsukiyo-Cocokara Merger: Quantamental Analysis Shows Matsukiyo in Fact IS the Best Fit
After the close today Cocokara Fine (3098 JP) announced the details of its MOU with Matsumotokiyoshi Holdings Co (3088 JP) for exclusive...
Mio Kato
Follow
681 Views
Share
bearish
•
Cocokara Fine
•
15 Aug 2019 05:47
Cocokara (3098) Going With MatsuKiyo (3088) But Ratio Overextended
A couple of minutes before the AM session close yesterday, the Nikkei Inc released a story saying that the Special Committee formed to help...
Travis Lundy
Follow
846 Views
Share
bullish
•
Cocokara Fine
•
12 Jun 2019 23:00
Drug-Fuelled Marriages and Macho Shachos* in Japan
The Japanese drugstore sector has been consolidating fast for a decade led by Aeon's (8267 JP) Welcia subsidiary, Tsuruha Holdings (3391 JP) and...
Michael Causton
Follow
1.1k Views
Share
First
Previous
5
6
7
8
9
10
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x